Retatrutide (RETA) — 10mg

Retatrutide is a next-generation triple agonist peptide (GLP-1/GIP/Glucagon), currently one of the most studied compounds in obesity and metabolic research. It simultaneously targets three key hormonal receptors to regulate appetite, energy expenditure, and fat metabolism.

Mechanism of Action

• GLP-1 agonist: Reduces appetite and slows gastric emptying
• GIP agonist: Improves insulin sensitivity and energy storage
• Glucagon agonist: Increases energy expenditure and lipolysis

Research Areas

• Obesity and weight management
• Insulin resistance and type 2 diabetes
• Non-alcoholic fatty liver disease (NAFLD)

⚠️ Research Use Only (RUO) Notice

All products available on PeptidesLab.tech are strictly intended for laboratory research purposes only. They are not intended for human or animal consumption, and must not be used for medical, therapeutic, or diagnostic applications under any circumstances.

By purchasing from this website, you acknowledge and agree that you are a qualified professional or researcher, and that you fully understand the nature and risks associated with handling research-use-only substances.

PeptidesLab.tech reserves the right to request proof of professional or research status prior to processing or shipping any order. Failure to provide adequate documentation upon request may result in order cancellation at our sole discretion.